Ogeda – former Euroscreen

Confo Therapeutics

Confo Therapeutics develops G-protein coupled receptor medicines for metabolic and endocrine diseases and provides drug discovery technology to global pharmaceutical companies.

Augustine Therapeutics

This company develops small molecule inhibitors to treat patients with neuromuscular, neurodegenerative and cardio-metabolic diseases.

Gesynta Pharma

This company develops anti-inflammatory and pain-relieving oral pharmaceuticals targeting the mPGES-1 enzyme for patients with endometriosis and chronic inflammatory conditions.

Septerna, Inc

This biotechnology company develops small-molecule medicines targeting G protein-coupled receptors to treat patients with endocrine, inflammatory and metabolic diseases.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Scenic Biotech

This company develops disease-modifying small molecule therapeutics for patients with rare genetic and neurodegenerative disorders using its proprietary genetic modifier discovery platform.

Gesynta

This pharmaceutical company develops non-hormonal oral treatments targeting chronic inflammation and pain for patients with endometriosis and other inflammatory conditions.